1. Home
  2. SLDB vs CCB Comparison

SLDB vs CCB Comparison

Compare SLDB & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$41.30

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
CCB
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
SLDB
CCB
Price
$8.11
$41.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$16.36
$126.67
AVG Volume (30 Days)
1.2M
181.9K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
N/A
EPS
N/A
0.78
Revenue
$8,094,000.00
N/A
Revenue This Year
N/A
$96.61
Revenue Next Year
N/A
$22.66
P/E Ratio
N/A
$51.40
Revenue Growth
N/A
N/A
52 Week Low
$3.79
$36.61
52 Week High
$11.45
$120.05

Technical Indicators

Market Signals
Indicator
SLDB
CCB
Relative Strength Index (RSI) 43.63 12.38
Support Level $6.25 N/A
Resistance Level $8.67 $83.23
Average True Range (ATR) 0.45 4.03
MACD -0.16 -4.11
Stochastic Oscillator 24.95 6.15

Price Performance

Historical Comparison
SLDB
CCB

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company.

Share on Social Networks: